15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 1 firms covering Evotec SE ADR, 1 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $4.00 to $4.00, so the covering firms are broadly aligned. The average target of $4.00 sits 108% above the current $1.93. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.20 next quarter toward $-0.34 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS1 ratings
Moderate Buy
Strong Buy00%
Buy1100%
Hold00%
Sell00%
Strong Sell00%
Based on 1 analysts giving stock ratings to Evotec SE ADR.
As of Jul, 1 of 1 firms rate EVO a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
EVO EPS & revenue forecast
EPS · NEXT QUARTER
$-0.20
Range $-0.34 – $-0.07 · 2 analysts · +71% YoY
Next period, 2 analysts expect Evotec SE ADR to earn $-0.20 a share (range $-0.34 – $-0.07), versus $-0.12 a year earlier. Full-year consensus is $-1.10, growing to $-0.34 the year after.
REVENUE · NEXT QUARTER
$146.1M
Range $127.0M – $169.0M · 2 analysts · -11% YoY
Revenue is expected to reach $146.1M (range $127.0M – $169.0M), -10.8% year-over-year. Full-year consensus is $599.7M, rising to $736.1M next year.
Top analysts covering Evotec SE ADR
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on EVO.
#1
Douglas Tsao
HC Wainwright & Co. · Rank #212
Buy
$7.00+263.6% to target
Overall win rate
35%
+ Follow
#2
Swayampakula Ramakanth
HC Wainwright & Co. · Rank #230
Buy
$4.00+107.8% to target
Overall win rate
37%
+ Follow
#3
BJ
Benjamin Jackson
Jefferies
Hold
$3.80+97.4% to target
Coverage
—
+ Follow
EVO stock forecast FAQ
What is EVO's average 12-month price target?+
The 1 analysts with a live target average $4.00 for Evotec SE ADR over the next 12 months, ranging from a $4.00 high to a $4.00 low.
Is EVO stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 1 analyst ratings, 1 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
How many Wall Street analysts cover EVO?+
1 analysts have an active rating on Evotec SE ADR, and 1 firms carry a live 12-month price target.
Who is the most accurate analyst covering EVO?+
Among analysts who currently cover EVO, Douglas Tsao of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #212). Their current call is Buy with a $7.00 target.
What is Evotec SE ADR's projected EPS for next quarter?+
The consensus estimate is $-0.20 per share (range $-0.34 – $-0.07) across 2 analysts. Full-year EPS is projected at $-1.10, rising to $-0.34 the following year.
How much revenue is Evotec SE ADR expected to report next quarter?+
Consensus revenue is $146.1M (range $127.0M – $169.0M). Full-year revenue is projected at $599.7M, growing to $736.1M next year.
Have analysts been upgrading or downgrading EVO lately?+
As of Jul, 1 of 1 firms rate EVO a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their EVO calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
